<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35216672</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>185</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Multiple early factors anticipate post-acute COVID-19 sequelae.</ArticleTitle><Pagination><StartPage>881</StartPage><EndPage>895.e20</EndPage><MedlinePgn>881-895.e20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2022.01.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(22)00072-1</ELocationID><Abstract><AbstractText>Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However, quantifiable risk factors for PASC and their biological associations are poorly resolved. We executed a deep multi-omic, longitudinal investigation of 309 COVID-19 patients from initial diagnosis to convalescence (2-3&#xa0;months later), integrated with clinical data and patient-reported symptoms. We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies. In patients with gastrointestinal PASC, SARS-CoV-2-specific and CMV-specific CD8<sup>+</sup> T&#xa0;cells exhibited unique dynamics during recovery from COVID-19. Analysis of symptom-associated immunological signatures revealed coordinated immunity polarization into four endotypes, exhibiting divergent acute severity and PASC. We find that immunological associations between PASC factors diminish over time, leading to distinct convalescent immune states. Detectability of most PASC factors at COVID-19 diagnosis emphasizes the importance of early disease measurements for understanding emergent chronic conditions and suggests PASC treatment strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Yapeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Electronic address: suyapeng.tju@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Daniel G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Microbiology and Department of Informatics, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Rachel H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jongchan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Sunga</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rongyu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Molecular Engineering &amp; Sciences Institute, University of Washington, Seattle, WA 98105, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kornilov</LastName><ForeName>Sergey A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherler</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavlovitch-Bedzyk</LastName><ForeName>Ana Jimena</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Shen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lausted</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Inyoul</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fallen</LastName><ForeName>Shannon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Chengzhen L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baloni</LastName><ForeName>Priyanka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duvvuri</LastName><ForeName>Venkata R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Kristin G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Departments of Immunology and Medicine, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University, Stanford, CA 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncombe</LastName><ForeName>Caroline J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Division of Global Health, University of Washington, Seattle, WA 98105, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCulloch</LastName><ForeName>Denise J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rostomily</LastName><ForeName>Clifford</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troisch</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Isoplexis Corporation, Branford, CT 06405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackay</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Isoplexis Corporation, Branford, CT 06405, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeGottardi</LastName><ForeName>Quinn</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Adaptive Biotechnologies, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Damon H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Adaptive Biotechnologies, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniguchi</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Adaptive Biotechnologies, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gittelman</LastName><ForeName>Rachel M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Adaptive Biotechnologies, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klinger</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Adaptive Biotechnologies, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snyder</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Adaptive Biotechnologies, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roper</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojciechowska</LastName><ForeName>Gladys</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Medical University of Bia&#x142;ystok, Bia&#x142;ystok 15089, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edmark</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Lesley</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowen</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chour</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Algren</LastName><ForeName>Heather A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berrington</LastName><ForeName>William R</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallick</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cochran</LastName><ForeName>Rebecca A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Micikas</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ISB-Swedish COVID-19 Biobanking Unit</CollectiveName><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wrin</LastName><ForeName>Terri</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petropoulos</LastName><ForeName>Christos J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cole</LastName><ForeName>Hunter R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>St. John's Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Trevan D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>St. John's Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoon</LastName><ForeName>Dave S B</ForeName><Initials>DSB</Initials><AffiliationInfo><Affiliation>St. John's Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Nathan D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Naeha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Global Heath and Department of Immunology, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Joshua A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadlock</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magis</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribas</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, Los Angeles, and Parker Institute for Cancer Immunotherapy, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanier</LastName><ForeName>Lewis L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of California, San Francisco, and Parker Institute for Cancer Immunotherapy, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>Scott D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University, Stanford, CA 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bluestone</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Global Health, University of Washington, Seattle, WA 98105, USA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hood</LastName><ForeName>Leroy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottardo</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Statistics, University of Washington, Seattle, WA 98195, USA; Biomedical Data Sciences, Lausanne University Hospital, University of Lausanne, Lausanne, 1011, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Philip D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Departments of Immunology and Medicine, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; The Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldman</LastName><ForeName>Jason D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA; Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA. Electronic address: jason.goldman@swedish.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heath</LastName><ForeName>James R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA. Electronic address: jim.heath@isbscience.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI007290</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007334</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI138258</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA040395</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG3 TR002884</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI068129</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI153559</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI155685</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007044</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI057229</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI128914</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI163131</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003289" MajorTopicYN="Y">Convalescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">RNAemia</Keyword><Keyword MajorTopicYN="N">antibodies</Keyword><Keyword MajorTopicYN="N">auto-antibodies</Keyword><Keyword MajorTopicYN="N">computational biology</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">immunology</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">multi-omics</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword><Keyword MajorTopicYN="N">single cell</Keyword><Keyword MajorTopicYN="N">single-cell CITE-seq</Keyword><Keyword MajorTopicYN="N">single-cell RNA-seq</Keyword><Keyword MajorTopicYN="N">single-cell TCR-seq</Keyword><Keyword MajorTopicYN="N">single-cell secretome</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword><Keyword MajorTopicYN="N">transcriptome</Keyword><Keyword MajorTopicYN="N">viremia</Keyword></KeywordList><CoiStatement>Declaration of interests J.R.H. and A.R. are founders and board members of PACT Pharma. J.R.H. is a board member of Isoplexis, and A.R. is the scientific advisor to Isoplexis. M.M.D. is a member of the Scientific Advisory Board of PACT Pharma. J.A.B. is a member of the Scientific Advisory Boards of Arcus, Solid, and VIR. J.A.B. is a member of the Board of Directors of Gilead and Provention. J.A.B. is the CEO of Sonoma Biotherapeutics. L.L.L. is on the scientific advisory boards of Alector, Atreca, Dragonfly, DrenBio, Nkarta, Obsidian Therapeutics, and SBI Biotech. R.G. has received consulting income from Juno Therapeutics, Takeda, Infotech Soft, Celgene, and Merck, has received research support from Janssen Pharmaceuticals and Juno Therapeutics, and declares ownership in CellSpace Biosciences. P.D.G. is on the Scientific Advisory Board of Celsius, Earli, Elpiscience, Immunoscape, Rapt, and Nextech, was a scientific founder of Juno Therapeutics, and receives research support from Lonza. J.D.G. declared contracted research with Gilead, Lilly, and Regeneron. J.A.H. received consulting fees or honoraria from Gilead Sciences, Amplyx, Allovir, Allogene therapeutics, CRISPR therapeutics, CSL Behring, OptumHealth, Octapharma, and Takeda and research funding from Takeda, Allovir, Karius, and Gilead Sciences. Q.D., D.H.M., R.T., R.M.G., M.K., and T.M.S. have employment and equity ownership with Adaptive Biotechnologies. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35216672</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pii">S0092-8674(22)00072-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Altschul S.F., Madden T.L., Sch&#xe4;ffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389&#x2013;3402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC146917</ArticleId><ArticleId IdType="pubmed">9254694</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziato F., Romagnani C., Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J.&#xa0;Allergy Clin. Immunol. 2015;135:626&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">25528359</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagaev D.V., Vroomans R.M.A., Samir J., Stervbo U., Rius C., Dolton G., Greenshields-Watson A., Attaf M., Egorov E.S., Zvyagin I.V., et al. VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium. Nucleic Acids Res. 2020;48:D1057&#x2013;D1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943061</ArticleId><ArticleId IdType="pubmed">31588507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Manry J., Michailidis E., Hoffmann H.H., Eto S., Garcia-Prat M., et al. Autoantibodies neutralizing type I IFNs are present in &#x223c;4% of uninfected individuals over 70 years old and account for &#x223c;20% of COVID-19 deaths. Sci. Immunol. 2021;6 eabl4340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun D., Caramalho I., Demengeot J. IFN-alpha/beta enhances BCR-dependent B cell responses. Int. Immunol. 2002;14:411&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">11934877</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown S.M., Bose S., Banner-Goodspeed V., Beesley S.J., Dinglas V.D., Hopkins R.O., Jackson J.C., Mir-Kasimov M., Needham D.M., Sevin C.M., et al. Approaches to addressing post-intensive care syndrome among intensive care unit survivors. A narrative review. Ann. Am. Thorac. Soc. 2019;16:947&#x2013;956.</Citation><ArticleIdList><ArticleId IdType="pubmed">31162935</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson C.S., Emerson R.O., Sherwood A.M., Desmarais C., Chung M.W., Parsons J.M., Steen M.S., LaMadrid-Herrmannsfeldt M.A., Williamson D.W., Livingston R.J., et al. Using synthetic templates to design an unbiased multiplex PCR assay. Nat. Commun. 2013;4:2680.</Citation><ArticleIdList><ArticleId IdType="pubmed">24157944</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  . 2020. CDC&#x2019;s diagnostic test for COVID-19 only and supplies.https://www.cdc.gov/coronavirus/2019-ncov/lab/virus-requests.html</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  Post-COVID conditions. 2021. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Chang S.E., Feng A., Meng W., Apostolidis S.A., Mack E., Artandi M., Barman L., Bennett K., Chakraborty S., Chang I., et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 2021;12:5417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapuis A.G., Egan D.N., Bar M., Schmitt T.M., McAfee M.S., Paulson K.G., Voillet V., Gottardo R., Ragnarsson G.B., Bleakley M., et al. T&#xa0;cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. Nat. Med. 2019;25:1064&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6982533</ArticleId><ArticleId IdType="pubmed">31235963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Guestrin C. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. Association for Computing Machinery; 2016. XGBoost: a scalable tree boosting system; pp. 785&#x2013;794.</Citation></Reference><Reference><Citation>Choi M.Y., FitzPatrick R.D., Buhler K., Mahler M., Fritzler M.J. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. Autoimmun. Rev. 2020;19:102463.</Citation><ArticleIdList><ArticleId IdType="pubmed">31927088</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy K.W. Cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 2020;8:808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492026</ArticleId><ArticleId IdType="pubmed">32946816</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H.Y., Englund J.A., Starita L.M., Famulare M., Brandstetter E., Nickerson D.A., Rieder M.J., Adler A., Lacombe K., Kim A.E., et al. Early detection of COVID-19 through a citywide pandemic surveillance platform. N.&#xa0;Engl. J. Med. 2020;383:185&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206929</ArticleId><ArticleId IdType="pubmed">32356944</ArticleId></ArticleIdList></Reference><Reference><Citation>Commo F., Bot B.M.  2016. nplr: N-Parameter logistic regression. R package version 0.1-7, URL  https://cran.r-project.org/package=nplr.</Citation></Reference><Reference><Citation>Davidson-Pilon C. lifelines: survival analysis in Python. J.&#xa0;Open Source Softw. 2021;4:1317.</Citation></Reference><Reference><Citation>Domeier P.P., Chodisetti S.B., Schell S.L., Kawasawa Y.I., Fasnacht M.J., Soni C., Rahman Z.S.M. B-cell-intrinsic Type 1 interferon signaling is crucial for loss of tolerance and the development of autoreactive B cells. Cell Rep. 2018;24:406&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6089613</ArticleId><ArticleId IdType="pubmed">29996101</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerson R.O., DeWitt W.S., Vignali M., Gravley J., Hu J.K., Osborne E.J., Desmarais C., Klinger M., Carlson C.S., Hansen J.A., et al. Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T&#xa0;cell repertoire. Nat. Genet. 2017;49:659&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pubmed">28369038</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C., Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat. Rev. Rheumatol. 2020;16:413&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts D.R., Getts M.T., King N.J.C., Miller S.D. In: The Autoimmune Diseases. Fifth Edition. Rose N.R., Mackay I.R., editors. Elsevier Inc.; 2014. Chapter 19. Infectious triggers of T&#xa0;cell autoimmunity; pp. 263&#x2013;274.</Citation></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10:763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman J.D., Wang K., Roltgen K., Nielsen S.C.A., Roach J.C., Naccache S.N., Yang F., Wirz O.F., Yost K.E., Lee J.Y., et al. Reinfection with SARS-CoV-2 and failure of humoral immunity: a case report. medRxiv. 2020 doi: 10.1101/2020.09.22.20192443. medRxiv:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.22.20192443</ArticleId><ArticleId IdType="pmc">PMC9861578</ArticleId><ArticleId IdType="pubmed">36679852</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open. 2021;4:e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., F&#xf6;rster I., Farlik M., Decker T., Du Pasquier R.A., Romero P., et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011;34:213&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">21349431</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann C., Takov K., Burnap S.A., Singh B., Ali H., Theofilatos K., Reed E., Hasman M., Nabeebaccus A., Fish M., et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat. Commun. 2021;12:3406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8184784</ArticleId><ArticleId IdType="pubmed">34099652</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>ImmunoMind Team Immunarch: an R package for painless bioinformatics analysis of T-cell and B-cell immune repertoires. Zenodo. 2019 doi: 10.5281/zenodo.3367200.</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.3367200</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks S.A., Cashman K.S., Zumaquero E., Marigorta U.M., Patel A.V., Wang X., Tomar D., Woodruff M.C., Simon Z., Bugrovsky R., et al. Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity. 2018;49:725&#x2013;739.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D.H., Roy D.J., Gu B.J., Hassett L.C., McCoy R.G. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: a state-of-the-art review. JACC Basic Transl. Sci. 2021;6:796&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8442719</ArticleId><ArticleId IdType="pubmed">34541421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2002;2:251&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">12001996</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinger M., Pepin F., Wilkins J., Asbury T., Wittkop T., Zheng J., Moorhead M., Faham M. Multiplex identification of antigen-specific T&#xa0;cell receptors using a combination of immune assays and immune receptor sequencing. PLoS One. 2015;10:e0141561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4624875</ArticleId><ArticleId IdType="pubmed">26509579</ArticleId></ArticleIdList></Reference><Reference><Citation>Koizumi S.I., Sasaki D., Hsieh T.H., Taira N., Arakaki N., Yamasaki S., Wang K., Sarkar S., Shirahata H., Miyagi M., et al. JunB regulates homeostasis and suppressive functions of effector regulatory T&#xa0;cells. Nat. Commun. 2018;9:5344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6297218</ArticleId><ArticleId IdType="pubmed">30559442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M. Building predictive models in R using the caret package. J.&#xa0;Stat. Softw. 2008;28:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang R., Raffi F.A.M. Dual-specificity phosphatases in immunity and infection: an update. Int. J. Mol. Sci. 2019;20:2710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6600418</ArticleId><ArticleId IdType="pubmed">31159473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.W., Su Y., Baloni P., Chen D., Pavlovitch-Bedzyk A.J., Yuan D., Duvvuri V.R., Ng R.H., Choi J., Xie J., et al. Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nat. Biotechnol. 2022;40:110&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9206886</ArticleId><ArticleId IdType="pubmed">34489601</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in adults at 6&#xa0;months after COVID-19 infection. JAMA Netw. Open. 2021;4:e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Maechler M., Rousseeuw P., Croux C., Todorov V., Ruckstuhl A., Salibian-Barrera M., Verbeke T., Koller M., Conceicao E.L.T., Anna di Palma M.  2021. robustbase: Basic Robust Statistics. R package version 0; pp. 93&#x2013;99.http://robustbase.r-forge.r-project.org/</Citation></Reference><Reference><Citation>Manor O., Zubair N., Conomos M.P., Xu X., Rohwer J.E., Krafft C.E., Lovejoy J.C., Magis A.T. A multi-omic association study of trimethylamine N-oxide. Cell Rep. 2018;24:935&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pubmed">30044989</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D., Giles J.R., Baxter A.E., Oldridge D.A., Greenplate A.R., Wu J.E., Alanio C., Kuri-Cervantes L., Pampena M.B., D&#x2019;Andrea K., et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369 eabc8511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes L., Healy J., Melville J. UMAP: uniform manifold approximation and projection for dimension reduction. arXiv. 2020 arXiv:1802.03426v3.</Citation></Reference><Reference><Citation>Michalska A., Blaszczyk K., Wesoly J., Bluyssen H.A.R. A positive feedback amplifier circuit that regulates interferon (IFN)-stimulated gene expression and controls type I and Type II IFN responses. Front. Immunol. 2018;9:1135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5985295</ArticleId><ArticleId IdType="pubmed">29892288</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L.D., Ehrlich B.E. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Mol. Med. 2020;12:e12075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7278555</ArticleId><ArticleId IdType="pubmed">32346964</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan S., Vignali M., Klinger M., Dines J.N., Kaplan I.M., Svejnoha E., Craft T., Boland K., Pesesky M., Gittelman R.M., et al. A large-scale database of T-cell receptor beta (TCR&#x3b2;) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2. Res. Sq. 2020 doi: 10.21203/rs.3.rs-51964/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-51964/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliviero B., Varchetta S., Mele D., Mantovani S., Cerino A., Perotti C.G., Ludovisi S., Mondelli M.U. Expansion of atypical memory B cells is a prominent feature of COVID-19. Cell. Mol. Immunol. 2020;17:1101&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7463104</ArticleId><ArticleId IdType="pubmed">32879471</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen L.F., Degn H. Chaos in biological systems. Q.&#xa0;Rev. Biophys. 1985;18:165&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">3912797</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasa S., Desai M., Thoguluva Chandrasekar V., Patel H.K., Kennedy K.F., Roesch T., Spadaccini M., Colombo M., Gabbiadini R., Artifon E.L.A., et al. Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus Disease 2019: a systematic review and meta-analysis. JAMA Netw. Open. 2020;3:e2011335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290409</ArticleId><ArticleId IdType="pubmed">32525549</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F., Varoquaux G., Gramfort A., Michel V., Thirion B., Grisel O., Blondel M., Prettenhofer P., Weiss R., Dubourg V., et al. Scikit-learn: machine learning in Python. J.&#xa0;Mach. Learn. Res. 2011;12:2825&#x2013;2830.</Citation></Reference><Reference><Citation>Pisetsky D.S. Antinuclear antibodies in healthy people: the tip of autoimmunity&#x2019;s iceberg? Arthritis Res. Ther. 2011;13:109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3132028</ArticleId><ArticleId IdType="pubmed">21554754</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisetsky D.S., Lipsky P.E. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat. Rev. Rheumatol. 2020;16:565&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456518</ArticleId><ArticleId IdType="pubmed">32884126</ArticleId></ArticleIdList></Reference><Reference><Citation>Pola&#x144;ski K., Young M.D., Miao Z., Meyer K.B., Teichmann S.A., Park J.E. BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics. 2020;36:964&#x2013;965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9883685</ArticleId><ArticleId IdType="pubmed">31400197</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:698169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Providence  . 2021. MyCovidDiary.http://mycoviddiary.org/</Citation></Reference><Reference><Citation>Puar T.H.K., Stikkelbroeck N.M.M.L., Smans L.C.C.J., Zelissen P.M.J., Hermus A.R.M.M. Adrenal crisis: still a deadly event in the 21st Century. Am. J. Med. 2016;129 339.e1&#x2013;339.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26363354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan R.K., Kashour T., Hamid Q., Halwani R., Tleyjeh I.M. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front. Immunol. 2021;12:686029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: an overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebman A.W., Aucott J.N. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front. Med. (Lausanne) 2020;7:57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7052487</ArticleId><ArticleId IdType="pubmed">32161761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X., Wen W., Fan X., Hou W., Su B., Cai P., Li J., Liu Y., Tang F., Zhang F., et al. COVID-19 immune features revealed by a large-scale single cell transcriptome atlas. Cell. 2021;184:1895&#x2013;1913.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857060</ArticleId><ArticleId IdType="pubmed">33657410</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins H.S., Campregher P.V., Srivastava S.K., Wacher A., Turtle C.J., Kahsai O., Riddell S.R., Warren E.H., Carlson C.S. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T&#xa0;cells. Blood. 2009;114:4099&#x2013;4107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2774550</ArticleId><ArticleId IdType="pubmed">19706884</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ltgen K., Boyd S.D. Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe. 2021;29:1063&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233571</ArticleId><ArticleId IdType="pubmed">34174992</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J., Reusch N., Paclik D., Ba&#xdf;ler K., Schlickeiser S., Zhang B., Kr&#xe4;mer B., Krammer T., Brumhard S., Bonaguro L., et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419&#x2013;1440.e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Slight-Webb S., Lu R., Ritterhouse L.L., Munroe M.E., Maecker H.T., Fathman C.G., Utz P.J., Merrill J.T., Guthridge J.M., James J.A. Autoantibody-positive healthy individuals display unique immune profiles that may regulate autoimmunity. Arthritis Rheumatol. 2016;68:2492&#x2013;2502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5042816</ArticleId><ArticleId IdType="pubmed">27059145</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti M.K., Cyprian F.S., Nasrallah G.K., Al Thani A.A., Almishal R.O., Yassine H.M. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11:762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder T.M., Gittelman R.M., Klinger M., May D.H., Osborne E.J., Taniguchi R., Zahid H.J., Kaplan I.M., Dines J.N., Noakes M.T., et al. Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels. medRxiv. 2020 doi: 10.1101/2020.07.31.20165647. medRxiv:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.31.20165647</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokal A., Chappert P., Barba-Spaeth G., Roeser A., Fourati S., Azzaoui I., Vandenberghe A., Fernandez I., Meola A., Bouvier-Alias M., et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201&#x2013;1213.e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7994111</ArticleId><ArticleId IdType="pubmed">33571429</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson E., Reynolds G., Botting R.A., Calero-Nieto F.J., Morgan M.D., Tuong Z.K., Bach K., Sungnak W., Worlock K.B., Yoshida M., et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 2021;27:904&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121667</ArticleId><ArticleId IdType="pubmed">33879890</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturm G., Szabo T., Fotakis G., Haider M., Rieder D., Trajanoski Z., Finotello F. Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor sequencing data. Bioinformatics. 2020;36:4817&#x2013;4818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751015</ArticleId><ArticleId IdType="pubmed">32614448</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Chen D., Yuan D., Lausted C., Choi J., Dai C.L., Voillet V., Duvvuri V.R., Scherler K., Troisch P., et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell. 2020;183:1479&#x2013;1495.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan E.M., Feltkamp T.E., Smolen J.S., Butcher B., Dawkins R., Fritzler M.J., Gordon T., Hardin J.A., Kalden J.R., Lahita R.G., et al. Range of antinuclear antibodies in &#x201c;healthy&#x201d; individuals. Arthritis Rheum. 1997;40:1601&#x2013;1611.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324014</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Traag V.A., Waltman L., van Eck N.J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 2019;9:5233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6435756</ArticleId><ArticleId IdType="pubmed">30914743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside S.K., Snook J.P., Williams M.A., Weis J.J. Bystander T&#xa0;cells: a balancing act of friends and foes. Trends Immunol. 2018;39:1021&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6269193</ArticleId><ArticleId IdType="pubmed">30413351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf F.A., Angerer P., Theis F.J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5802054</ArticleId><ArticleId IdType="pubmed">29409532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolock S.L., Lopez R., Klein A.M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 2019;8:281&#x2013;291.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625319</ArticleId><ArticleId IdType="pubmed">30954476</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., Ramonell R.P., Lee F.E.-H., Sanz I. Clinically identifiable autoreactivity is common in severe SARS-CoV-2 Infection. medRxiv. 2020 doi: 10.1101/2020.10.21.20216192. medRxiv:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.21.20216192</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  . 2020. WHO R&amp;D blueprint novel coronavirus COVID-19 therapeutic trial synopsis.https://www.who.int/blueprint/priority-diseases/key-action/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf</Citation></Reference><Reference><Citation>Ye J., Ma N., Madden T.L., Ostell J.M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 2013;41:W34&#x2013;W40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3692102</ArticleId><ArticleId IdType="pubmed">23671333</ArticleId></ArticleIdList></Reference><Reference><Citation>Younes A.K., Younes N.K. Recovery of steroid induced adrenal insufficiency. Transl. Pediatr. 2017;6:269&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5682381</ArticleId><ArticleId IdType="pubmed">29184808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani B., Moeini Taba S.M., Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J.&#xa0;Med. Case Rep. 2021;15:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832415</ArticleId><ArticleId IdType="pubmed">33494816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M.M., Yang W.L., Yang F.Y., Zhang L., Huang W.J., Hou W., Fan C.F., Jin R.H., Feng Y.M., Wang Y.C., et al. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct. Target. Ther. 2021;6:134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997800</ArticleId><ArticleId IdType="pubmed">33774649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Rao A.M., Dermadi D., Toh J., Murphy Jones L., Donato M., Liu Y., Su Y., Dai C.L., Kornilov S.A., et al. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity. 2021;54:753&#x2013;768.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7988739</ArticleId><ArticleId IdType="pubmed">33765435</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>